Home » News from Way2Global » News » Laura Gori on CSR, Benefit Corporations and the Way2Global model
Way2Global CEO and founder Laura Gori was interviewed by Koinética president Rossella Sobrero this week. The result was a fascinating exchange of ideas, focusing on Way2Global’s commitments as a Benefit Corporation and Certified B Corp to Corporate Social Responsibility (CSR) and sustainability.
In the interview – which can be read in full here – Gori provides a passionate account of the Way2Global mission and worldview, which is centred on promoting communication and comprehension through translation services. The company helps people and organisations overcome linguistic and cultural barriers to create a better, more inclusive, more collaborative world.
This commitment has been at the heart of the company’s mission since Way2Global was set up as a Benefit Corporation, which set in stone its desire to favour environmental and social issues over profit.
The interview also touched on some of the core principles at Way2Global – the central tenets of our Benefit Corporation ethos – including innovation in the language industry, the need to keep organisations cohesive as they grow, projects encompassing research and development, open innovation and technology transfer, and ways to keep stakeholders engaged and the company’s past, present and future activities.
Contact
Ethical governance is now essential for companies seeking to distinguish themselves in a market that increasingly prioritizes sustainability and corporate social responsibility. This article explores how adopting […]
Read moreSustainability reporting is undergoing a profound transformation, driven by the latest EU regulations. This year, we also took part in the conference on “Italian best practices […]
Read moreParticipating in the Oscar di Bilancio 2024 financial reporting awards marked a significant milestone for Way2Global, reflecting our commitment to enhanced transparency and sustainability in corporate reporting. This […]
Read moreThe pharmaceutical patent is a fundamental tool in the pharmaceutical research and development sector, because it guarantees that innovation and the exclusive right of marketing are protected for […]
Read moreAccurate translation of package leaflets is a crucial component in the international drug market. The package leaflet, which accompanies every medication pack, contains vital information for safe, correct […]
Read moreProfessional translation of scientific articles is essential to making research results accessible to the international public. Even groundbreaking scientific articles risk limited impact if published in only […]
Read more